Hormone-resistant breast carcinoma
MONDO:0056813Breast carcinoma that does not respond to hormone therapy.
Also known as: hormone-refractory breast cancer, hormone-resistant breast cancer, hormone-resistant breast carcinoma
2809 clinical trials for this condition and its sub-types, 5 tagged with Hormone-resistant breast carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New combo aims to wipe out hidden breast cancer cells after standard treatment
Disease control Recruiting nowThis study tests whether adding the drug sarilumab to chemotherapy (capecitabine) can eliminate tiny amounts of cancer left behind after standard treatment in people with triple negative breast cancer, a very aggressive type. The goal is to prevent the cancer from coming back and…
Phase 1/2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Computer algorithm could unlock hidden treatments for aggressive breast cancer
Knowledge-focused Recruiting nowThis study tests whether a computer algorithm called ENLIGHT can help find better drug matches for people with advanced breast cancer that has stopped responding to standard treatments. About 175 adults with triple-negative or hormone-resistant breast cancer will have their tumor…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC